<SEC-DOCUMENT>0001021432-17-000028.txt : 20170302 <SEC-HEADER>0001021432-17-000028.hdr.sgml : 20170302 <ACCEPTANCE-DATETIME>20170302165530 ACCESSION NUMBER: 0001021432-17-000028 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170223 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year FILED AS OF DATE: 20170302 DATE AS OF CHANGE: 20170302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agate Island Acquisition Corp CENTRAL INDEX KEY: 0001672886 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 812310905 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55631 FILM NUMBER: 17659716 BUSINESS ADDRESS: STREET 1: 215 APOLENA AVE CITY: NEWPORT BEACH STATE: CA ZIP: 92662 BUSINESS PHONE: 9496734510 MAIL ADDRESS: STREET 1: 215 APOLENA AVE CITY: NEWPORT BEACH STATE: CA ZIP: 92662 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>form8kchgnameagatechinabio.txt <TEXT> SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 23, 2017 Date of Report (Date of Earliest Event Reported) CHINA BIOTECH COMPANY CORPORATION (Exact Name of Registrant as Specified in its Charter) AGATE ISLAND ACQUISITION CORPORATION (Former Name of Registrant as Specified in its Charter) Delaware 000-55631 81-2310905 (State or other (Commission File Number) (IRS Employer jurisdiction of incorporation) Identification No.) 9454 Wilshire Boulevard Suite 612 Beverly Hills, California 90212 (Address of principal executive offices) (zip code) 310-888-1870 (Registrant's telephone number, including area code ITEM 5.03 Amendments to Articles of Incorporation The shareholders of the Corporation and the Board of Directors unanimously approved the change of the Registrant's name to China Biotech Company Corporation and filed such change with the State of Delaware. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized. CHINA BIOTECH COMPANY CORPORATION Date: February 28, 2017 /s/ James Cassidy President </TEXT> </DOCUMENT> </SEC-DOCUMENT>